Microwave ablation for T1N1M0 papillary thyroid cancer with lymph node oligometastasis (≤3) – a preliminary study with median follow-up beyond 3 years

Zhenlong Zhao; Ying Wei; Jie Wu; Shi-Liang Cao; Na Yu; Yan Li; Wenjia Cai; Ming-An Yu

doi:10.1080/02656736.2025.2571047

October 13, 2025International Journal of HyperthermiaOpen Access

Microwave ablation for T1N1M0 papillary thyroid cancer with lymph node oligometastasis (≤3) – a preliminary study with median follow-up beyond 3 years

View Full Paper

Ask AI

Bookmark

Share

Key Points

Microwave ablation effectively treats T1N1M0 papillary thyroid cancer with lymph node oligometastasis.
Follow-up beyond 3 years highlights safety and lasting efficacy of this treatment.
Observational analysis of patients undergoing microwave ablation indicates promising outcomes.
Preliminary findings suggest that microwave ablation may offer a less invasive alternative for papillary thyroid cancer management.

Implication

Observational analysis shows the safety of microwave ablation in treating T1N1M0 papillary thyroid cancer with lymph node oligometastasis, indicating potential effectiveness.

Abstract

Objectives To evaluate the efficacy and safety of microwave ablation (MWA) for T1N1M0 PTC with LN oligometastasis (≤3).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhao et al. (2025) studied this question.

synapsesocial.com/papers/68efa18f9d05deea71d13f4e https://doi.org/10.1080/02656736.2025.2571047

View Full Paper

Ask AI

Bookmark

Share

Microwave ablation for T1N1M0 papillary thyroid cancer with lymph node oligometastasis (≤3) – a preliminary study with median follow-up beyond 3 years

Key Points

Implication

Abstract

Discussion

Cite This Study

Microwave ablation for T1N1M0 papillary thyroid cancer with lymph node oligometastasis (≤3) – a preliminary study with median follow-up beyond 3 years

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading